| Product NDC: | 0093-9612 |
| Proprietary Name: | Doxepin Hydrochloride |
| Non Proprietary Name: | Doxepin Hydrochloride |
| Active Ingredient(s): | 10 mg/mL & nbsp; Doxepin Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0093-9612 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA071609 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19871106 |
| Package NDC: | 0093-9612-12 |
| Package Description: | 120 mL in 1 BOTTLE, GLASS (0093-9612-12) |
| NDC Code | 0093-9612-12 |
| Proprietary Name | Doxepin Hydrochloride |
| Package Description | 120 mL in 1 BOTTLE, GLASS (0093-9612-12) |
| Product NDC | 0093-9612 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Doxepin Hydrochloride |
| Dosage Form Name | SOLUTION, CONCENTRATE |
| Route Name | ORAL |
| Start Marketing Date | 19871106 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | DOXEPIN HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Tricyclic Antidepressant [EPC] |